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Discussion results: The main research in the field aimed at depleting GSH by a specific 
inhibition of GCL, a key enzyme of GSH biosynthesis. But GSH depletion appears to be therapeutically 
effective when very low levels (<10% of their control values) can be achieved within the cancer cells. 
Thus, achievement of selective tumor GSH depletion under in vivo circumstances is a pharmacological 
challenge. Also, GSH synthesis and GSH synthesis-linked genes are up-regulated during oxidative stress 
and inflammation. Furthermore, Nrf-2 deficient cells were more susceptible to doxorubicin and BSO 
treatment-induced cell death than wild cells. Moreover, propyl gallate activated caspases 3, 8, and 9, and 
induced an increase in p53, Bax, Fas, and Fas Ligand; whereas MAPKs inhibited nuclear translocation 
of Nrf-2 and induced intracellular GSH depletion in human leukemia. This indicates that Nrf-2 is one of 
the first factors that induce cell survival under GSH depletion, which points out to this transcription 
factor as an attractive target in leukemia but also in other cancers sharing similar molecular mechanisms. 
The increase in GSH is a major contributing factor to drug resistance by binding to or reacting with, 
drugs, interacting with ROS, preventing damage to proteins or DNA, or by participating in DNA repair 
processes.
Conclusion: The modulation of cellular GSH is a double-edged sword. On one hand, enhancing 
the capacity of GSH and its Associated enzymes represents an aim in the search for cytoprotective 
strategies against cancer. On the other hand, the strategy of depleting GSH and GSH-related 
detoxification pathways is aimed at sensitizing cancer cells to chemotherapy. Keywords: Glutathione, 
cancer development, chemoresistance.
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Introduction: Despite the high level the human civilization achieved, we still constantly face 
dangers as viral infections, bacteria, traumas, chronic disease, cancer etc. Thanks to the development of 
medicine and pharmaceutics, antibiotics, anti-inflammatory and immunomodulatory drugs as well as 
cytostatic and cancer killing drugs were developed. Still, many of them have many adverse reactions, or 
are expensive, or both. That is why the discovery of Tuftsin in 1970 is considered one of a high value 
for the modern medicine, by offering new ways of treatment of the diseases, which endanger health and 
life.
Objectives and Purposes of this work was to identify the immunomodulatory, anti-
inflammatory, antibacterial and cancer killing properties of Tuftsin.
Materials and Methods: A bibliographic review of the scientific articles published over the 
studies of Tuftsin and its properties, during 1980-2012, was performed. 
Results: In 1970s, Victor A. Najjar and Kenji Nishioka found a new natural tetrapeptide (Thr-
Lys-Pro-Arg) derived from the proteolytic degradation of the 289–292 amino acid residues of the IgG 
heavy chain Fc domain that was named tuftsin. Tuftsin is produced by the action of two proteolytic 
enzymes – splenic tuftsin edocarboxypeptidase and leukokininase. 
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Further studies found out that Tuftsin and/or Tuftsin-like peptides increase immunologic effects 
like phagocyte respiratory burst, migration and chemotaxis ability, antigen presentation, etc. of cells of 
monocytic origin (macrophages, neutrophils, microglia and Kupffer cells). The peptide can be 
recognized by macrophages and microglia cells due to the expression of Tuftsin receptors. The receptors 
for Tuftsin react specifically to the Pro-Arg part of the peptide and the interaction of them raises the 
GMPc level in the target cell. In addition, the peptide is capable of targeting proteins to these cells. 
According to some studies, Tuftsin conjugates could increase production of antibodies and strengthen 
the humoral immune response to the antigen to which it was linked.
Still, in many animal disease models, such as sepsis (Wardowska et al., 2009), encephalomyelitis 
and multiple sclerosis (Bhasin M., et al., 2007), arthritis (Bashi T., et al., 2016), lupus nephritis (Bashi
T., et al., 2015) Tuftsin treatment has been Associated with anti-inflammatory effects. This proves the 
paradox effects of Tuftsin and its original immunomodulatory properties.
Tuftsin clinical developments was hampered because it is extremely susceptible to proteolytic 
degradation in vivo. To overcome this pitfall several derivatives have been synthesized. Their studies 
found out that these compounds exhibit similar activity as Tuftsin or even better properties. For example, 
it was described the ability of Tuftsin fragment 1-3 to inhibit macrophage and microglia and to decrease 
oxygen radicals production by activated microglia, thus reducing brain edema and tissue damage in 
animal models of brain ischemia. T peptide (TP), obtained by linking four tuftsin peptides, despite its 
limited effect in intact tumors, strongly inhibited postsurgical relapsed growth of residual tumors in 
mice. 
Conclusions: According to the presented data, Tuftsin presents different and useful properties 
that can be used in treating different severe diseases by rising the immune activity, as well as 
inflammatory processes by lowering it. It’s value as a medicine rises, by the fact that Tuftsin it is an 
endogenous substance proper to the patient’s body, thus being better accepted and having far more less 
adverse reactions than the rest of drugs, which is of a great importance.
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Introduction. Personality disorder is the inability to develop a sense of identity and the self-
commitment in the context of interpersonal functioning inability norms and cultural expectations of the 
subject that persists for several years and are not the result of other disorders.
The purpose of paper. The study aims to put in circulation in Republic of Moldova a tool for 
analyzing personality disorders.
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